Bioscience Across the North to Benefit from New United Life Sciences Collaboration
Bionow, the BioIndustry Association (BIA), BioPartner and One Nucleus (ON) has announced the formation of United Life Sciences, a strategic partnership representing more than 1000 life science and healthcare members across the UK and internationally. The aim of the partnership is to work together on a range of matters that directly benefit members including Bionow’s members in the north of the UK and the wider UK sector.
Today the partnership also publishes the Life Sciences Manifesto 2015–2020, which is being launched at the BIA’s UK Bioscience Forum in London. Led by the BIA, the four organisations have worked closely together on the Manifesto to pinpoint the key issues for the sector and make policy recommendations to government. Its three core messages to policy makers are
• Retain focus on strategically important technologies such as regenerative medicine and synthetic biology, which hold great potential to benefit the UK economy.
• Ensure a supportive tax and finance environment through continuing policies such as the Biomedical Catalyst, R&D Tax Credits and the Patent Box.
• Support new flexible routes to licensing, evaluation, uptake and reimbursement of cutting edge medicines and treatments to facilitate swift patient access. A centrally funded and reimbursed Early Access to Medicines Scheme and full utilisation of the European Medicine Agency’s Adaptive Licensing pilot will be required to achieve this aim.
Going forward United Life Sciences will
• Hold a series of UK roadshows to enable early stage companies access capital, understand the evolving policy landscape and grow their businesses.
• Promote and provide discounts for members on each other’s events.
• Work together to provide a combined approach at large international events.
The group has been working closely together informally for 2 years, and has already hosted several joint events both in the UK and overseas. The partnership will also be seeking new ways to collaborate with others in the sector.
Announcing the new partnership, Harriet Fear, CEO of One Nucleus, said: “Collaboration and partnership based on mutual respect and trust are the key hallmarks of successful organisations in bioscience and United Life Sciences works in this way too — it’s in my DNA to support the UK after 21 years of serving my country as a diplomat. Collaboration, as so many of our members are aware, is vitally important.”
Dr Geoff Davison, CEO of Bionow, said: “By working together we avoid duplication of effort, recognising that all our members are stretched in terms of their time and resources, plus it recognises the strengths and expertise of each of the four organisations. The partnership is totally focused upon and driven by the needs of the sector and representing over 1000 businesses means the group has international critical mass and clout.”
Steve Bates, CEO of the BIA, said: “Through this collaboration, all four organisations are fully committed to providing a united front and critically, one voice, to the government via the lobbying and advocacy work that the BIA undertakes for the sector.”
Lin Bateson, Executive Director of Biopartner UK, said: “Linking up to provide a combined approach will help to focus international attention on UK bioscience expertise to encourage growth, inward investment, and much-needed funding.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance